The effect of angostifolia in patients with Cirrhosis

The effect of adding angostifolia powder in addition to conventional medical treatment of liver cirrhosis on Levels of inflammatory markers in plasma and liver enzymes

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20100223003408N4

Enrollment

Registered

2018-12-03

Start date

2018-06-22

Completion date

Unknown

Last updated

2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver cirrhosis. Other and unspecified cirrhosis of liver

Interventions

Intervention 1: Control group : 15gr corn starch with 1glass water daily for 10 weeks in addition to conventional medical treatment of liver cirrhosis. Intervention 2: Intervention group :15gr angosti

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Person with Cirrhosis Age between 18 to 60 years

Exclusion criteria

Exclusion criteria: Diabetes Hypothyroidism or hyperthyroidism Kidney disease Lung disease Cardiovascular disease Smoking Alcohol and tobacco consumption

Design outcomes

Primary

Measure	Time frame
Tumor necrosis factor-alpha. Timepoint: Before intervention and 10 weeks after intervention. Method of measurement: ELISA.	—

Secondary

Measure	Time frame
Alanine aminotransferase. Timepoint: Before intervention and 10 weeks after intervention. Method of measurement: ALT Kit.;Aspartate transaminase. Timepoint: Before intervention and 10 weeks after intervention. Method of measurement: AST Kit.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Ekramzadeh

Shiraz University of Medical Sciences

Ekramzadeh@sums.ac.ir+98 71 3725 1001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026